4Accepted Aug 31, 6:40 PM ET
Synopsys (SNPS) Executive Chair Aart de Geus Sells 25,000 Shares
Accepted (ET)
6:40 PM
Aug 31, 2026
Filed
Aug 31, 2026
Documents
1
Size
10.0 KB
Summary
Synopsys (SNPS) Executive Chair Aart de Geus Sells 25,000 Shares
What Happened
Aart de Geus, Executive Chair and Director of Synopsys (SNPS), exercised 25,000 options at $135.88 ($3,397,000) and immediately sold 25,000 common shares in the open market for approximately $11,138,755 (weighted average $445.55) on August 28, 2026. The filing also reports a related derivative conversion of 25,000 shares shown at $0.00 (disposed) as part of the transaction record.
Key Details
- Transaction date: August 28, 2026. Form 4 filed Aug 31, 2026 (no late filing indicated in the document).
- Exercise: 25,000 shares exercised at $135.88 per share — total cost reported $3,397,000.
- Sale: 25,000 shares sold at a weighted average price of $445.55 — total proceeds reported $11,138,755. Sale prices ranged from $440.985 to $461.850 (footnote).
- Shares owned after transaction: Not specified in this Form 4.
- Notable footnotes: Transactions were effected under a Rule 10b5-1 trading plan adopted October 14, 2025. The filing provides a weighted-average sale price and offers to furnish per-trade price details on request.
Context
This sequence (option exercise followed by immediate sale) is commonly a cashless exercise: the insider exercises vested options and sells the resulting shares rather than holding them. The presence of a 10b5-1 plan indicates the sales were pre-planned trades executed according to a pre-established trading arrangement. The filing is factual and does not indicate the insider’s motivation.